GlassScriptPhysician profile
Valeri L Wolf
NPI 1457884405
$1,291.21
in general payments reported to CMS, 2019-2025
7 companies · $26.81 in 2025
The $26.81 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $215 · 2023: $1,000 · 2024: $49.63 · 2025: $26.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $770 · Education: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $770.34 |
| Education | $305.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $515.20 | 2022-2023 | Aequalis Perform Reversed, Salvation, Tornier Perform Reversed Augmented Glenoid |
| Zimmer Biomet Holdings, INC. | $425.89 | 2023 | Persona, Mymobility Platform, Rosa |
| Smith+Nephew, INC. | $154.82 | 2023 | Smart Tsf, Evos, Panta 2 |
| Endo Pharmaceuticals INC. | $119.95 | 2023-2024 | Xiaflex |
| Axogen | $33.70 | 2024 | Axoguard Nerve Protector, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Polynovo North America LLC | $26.81 | 2025 | Novosorb Btm |
| Cdc Medical LLC | $14.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Valeri Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.